In this study, we hypothesized that HPGDS, GSTZ1, and GSTA1 are abnormally expressed in multiple cancers and may promote the malignant progression of GBM by regulating intracellular GSH levels, thus affecting the prognosis of patients. The gene discussed is HPGDS; the disease is glioblastoma.